Canadian Hemophilia Society -

Title

FAQs – COVID-19 vaccine and bleeding disorders
CHS/SCH | 13/01/2021
The Association of Hemophilia Clinic Directors of Canada (AHCDC) has issued a message to address the most frequent questions asked with regards to the COVID-19 vaccine and bleeding disorders....

COVID-19 vaccination guidance for people with bleeding disorders
CHS/SCH | 07/01/2021
CLICK HERE to read the joint guidance notice from the World Federation of Hemophilia (WFH), European Association for Haemophilia and Allied Disorders (EAHAD), European Haemophilia Consortium (EHC), and U.S. National...

CHS James Kreppner Memorial Scholarship and Bursary Program
CHS/SCH | 02/12/2020
Information including the criteria and application forms for the CHS James Kreppner Memorial Scholarship and Bursary Program is available on the CHS website at www.hemophilia.ca/james-kreppner-memorial-scholarship-and-bursary-program. The deadline to submit...

COVID-19 updates
CHS/SCH | 14/10/2020
Access the most updated information regarding COVID-19 and inherited bleeding disorders: www.hemophilia.ca/covid-19

Features
- CHS/SCH | 21/12/2020
  FDA puts uniQure’s gene therapy clinical programme, HOPE-B, on hold following submission of a safety report
- CHS/SCH | 10/12/2020
  Announcement of a clinical trial for Vioxx for people with hemophilia
- David Page | 30/11/2020
  European Haemophilia Consortium New Products Review
- CHS/SCH | 09/11/2020
  Global dosing hold in fitusiran trials initiated by Sanofi Genzyme to investigate new adverse events
- CHS/SCH | 04/11/2020
  A Patient Videoconference on Inhibitors & New Novel Therapies – Answering Your Questions!
- CHS/SCH | 06/10/2020
  WFH Advisory: availability of desmopressin
- CHS/SCH | 23/09/2020
  Products in the pipeline
- CHS/SCH | 09/09/2020
  Coagulation products

INNOVATORS

BUILDER

Believers